PL - Planet Labs PBC
NYSE
->
Industrials
->
Aerospace & Defense
San Francisco,
United States
Type: Equity
PL price evolution
PL
| (in millions $) | 1 Dec 2024 | 31 Aug 2024 | 30 Jul 2024 | 2 Mar 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $38.85 | $43.93 | $38.53 | $43.32 |
| Inventory | ||||
| Total current assets | $301.59 | $326.75 | $345.96 | $370.15 |
| Long term investments | ||||
| Property, plant & equipment | $137.75 | $134.93 | $132.3 | $135.77 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $630.76 | $658.35 | $674.6 | $702 |
| Current liabilities | ||||
| Accounts payable | $3.57 | $2.39 | $3.13 | $2.6 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $129.08 | $139.68 | $126.38 | $136.65 |
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $166.16 | $185.1 | $174.28 | $183.98 |
| Shareholders' equity | ||||
| Retained earnings | -$1167.85 | -$1147.77 | -$1109.1 | -$1079.81 |
| Other shareholder equity | $1.35 | $1.25 | $0.55 | $1.59 |
| Total shareholder equity | ||||
| (in millions $) | 2 Mar 2024 | 3 Mar 2023 | 3 Mar 2022 | 3 Mar 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $43.32 | $38.95 | $44.37 | $47.11 |
| Inventory | ||||
| Total current assets | $370.15 | $475.65 | $551.52 | $125.43 |
| Long term investments | ||||
| Property, plant & equipment | $135.77 | $128.49 | $133.28 | $159.85 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $702 | $752.72 | $821.44 | $399.31 |
| Current liabilities | ||||
| Accounts payable | $2.6 | $6.9 | $2.85 | $1.45 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $136.65 | $122.26 | $132.04 | $108.81 |
| Long term debt | $155.61 | |||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $183.98 | $176.62 | $173.2 | $291.8 |
| Shareholders' equity | ||||
| Retained earnings | -$1079.81 | -$939.3 | -$777.03 | -$639.9 |
| Other shareholder equity | $1.59 | $2.27 | $2.1 | $1.77 |
| Total shareholder equity | ||||
| (in millions $) | 1 Dec 2024 | 31 Aug 2024 | 30 May 2024 | 2 Mar 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $61.27 | $61.09 | $60.44 | $58.85 |
| Cost of revenue | ||||
| Gross Profit | $37.65 | $33.49 | $31.68 | $32.48 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $60.23 | $62.57 | $66.25 | $66.36 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.03 | $0.9 | $0.44 | -$0.43 |
| Interest expense | $2.41 | $2.77 | $3.11 | $3.66 |
| Net income | ||||
| Net income | -$20.08 | -$38.67 | -$29.29 | -$30.09 |
| Income (for common shares) | ||||
| (in millions $) | 2 Mar 2024 | 3 Mar 2023 | 3 Mar 2022 | 3 Mar 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $220.7 | $191.3 | $131.21 | $113.17 |
| Cost of revenue | ||||
| Gross Profit | $113.78 | $94 | $48.22 | $25.79 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $273.84 | $269.7 | $175.17 | $113.23 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.81 | $0.8 | $2.11 | $1.07 |
| Interest expense | $15.41 | $14.2 | -$3.05 | -$39.5 |
| Net income | ||||
| Net income | -$140.51 | -$162 | -$137.12 | -$127.1 |
| Income (for common shares) | ||||
| (in millions $) | 1 Dec 2024 | 31 Aug 2024 | 30 May 2024 | 2 Mar 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $71.04 | $81.73 | $30.48 | -$33.59 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$15.3 | -$5.11 | -$2.38 | -$1.6 |
| Effect of exchange rate | $0.07 | -$0.03 | -$0.28 | $0.02 |
| Change in cash and equivalents | $47.73 | $64.43 | $23.54 | -$85.88 |
| (in millions $) | 2 Mar 2024 | 3 Mar 2023 | 3 Mar 2022 | 3 Mar 2021 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$33.59 | -$242.26 | -$25.15 | -$30.8 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$1.6 | $7.86 | $489.18 | $83.94 |
| Effect of exchange rate | $0.02 | -$0.4 | -$1.55 | -$0.31 |
| Change in cash and equivalents | -$85.88 | -$308.73 | $420.27 | $48.8 |
News
Fundamentals
| Market cap | $996.01M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 296.43M |
| Revenue | $241.65M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$118.13M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -8.43 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 4.12 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$0.40 |
|---|---|
| ROA | -17.73% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.34 |
| Quick ratio | N/A |